Adalta Ltd has released a press release.
AdAlta granted key Australian Patent
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AdAlta
- Commercial agreement with XL-protein
- Conference Presentation
- Results of multi-dose toxicology study
- AdAlta awarded SIEF grant
- Toxicology study and manufacturing update
Later from AdAlta
- AdAlta collaborator awarded NHMRC grant
- AdAlta to advance improved lung fibrosis therapy, AD-214
- Appendix 4C - Quarter Ended 31 March 2018
- AdAlta secures key manufacturing agreements for AD-214
- Completion of Capital Raise - $4.25m to advance AD-214
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta